1. 1756PA prospective analysis of 30-day mortality following palliative chemotherapy at an Australian tertiary cancer centre. (23rd October 2018) Authors: McCracken, J A; Dabscheck, A; Coperchini, M; Hornung, I; Jalali, A; Akers, G; Karahalios, A; Lipton, L Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 192PUse of folfirinox chemotherapy in an Australasian population of pancreatic cancer. (25th November 2018) Authors: Jalali, A; Lee, M; Semira, C; Banks, S; Wong, H-L; Ananda, S; Lipton, L; Shapiro, J D; Cooray, P; Clarke, K; Burge, M; Wong, R; Shapiro, J A; McLachlan, S-A; Harris, M; Croagh, D; Tebbutt, N; Gibbs, P; Lee, B Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Germline mutations in the TGF-β and Wnt signalling pathways are a rare cause of the "multiple" adenoma phenotype. Issue 4 (1st April 2003) Authors: Lipton, L; Sieber, O M; Thomas, H J W; Hodgson, S V; Tomlinson, I P M; Woodford-Richens, K Journal: Journal of medical genetics Issue: Volume 40:Issue 4(2003) Page Start: e35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗